ENG/中
美国
老虎证券
行情
产品介绍
Cash Boost账户
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登录
立即注册
Toggle
美股
详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务
NeOnc Technologies Holdings
6.05
-0.3800
-5.91%
成交量:
4.22万
成交额:
25.59万
市值:
1.13亿
市盈率:
-8.77
高:
6.59
开:
6.31
低:
5.82
收:
6.43
数据加载中...
总览
公司
新闻
公告
公司资料
公司名字:
NeOnc Technologies Holdings
交易所:
NASDAQ
成立时间:
2008
员工人数:
- -
公司地址:
Two Dole Drive,Westlake Village,California,United States
官网:
http://www.neonctech.com
邮编:
91362
电话:
310-663-7831
传真:
- -
简介:
Neonc Technologies Holdings, Inc.于2023年1月5日注册成立,为特拉华州公司。作为一家临床阶段的生物制药公司,该公司一直专注于建立颅内恶性肿瘤的治疗方法,即位于大脑的侵袭性癌症。这些癌症类型包括原发性脑癌,如胶质母细胞瘤,和继发性脑癌,它们是通过全身其他癌症的转移扩散而来的,如黑色素瘤或乳腺癌和肺癌。大脑局限性恶性肿瘤特别难以治疗,因为血脑屏障阻止了大多数药物治疗剂有效进入大脑。因此,这些患者面临着预后不良和平均预期寿命缩短的问题。NeOnc正在开发新的药物递送方法,用于与新的候选药物联合使用。
董事
名称
职位
Amir Heshmatpour
Executive Chairman and Secretary
Thomas C. Chen
Chief Executive Officer and Chairman
Keithly Garnett
Chief Financial Officer and Director
Bader Almonawer
Director
Jim Delshad
Director
Ming Fu Chiang
Director
Steven L. Giannotta
Director
Victoria Medvec
Director
股东
名称
职位
Thomas C. Chen
Chief Executive Officer and Chairman
Patrick Walters
Chief Operating Officer
Keithly Garnett
Chief Financial Officer and Director
Amir Heshmatpour
Executive Chairman and Secretary
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/NTHI/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NTHI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NTHI\",,,,,undefined,":{"symbol":"NTHI","market":"US","secType":"STK","nameCN":"NeOnc Technologies Holdings","latestPrice":6.05,"timestamp":1745344814767,"preClose":6.43,"halted":0,"volume":42196,"delay":0,"floatShares":5219711,"shares":18745865,"eps":-0.69,"marketStatus":"交易中","change":-0.38,"latestTime":"04-22 14:08:03 EDT","open":6.31,"high":6.5887,"low":5.82,"amount":255938.44553199998,"amplitude":0.119549,"askPrice":6.11,"askSize":100,"bidPrice":5.9,"bidSize":20,"shortable":0,"etf":0,"ttmEps":-0.69,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1745352000000},"marketStatusCode":2,"adr":0,"listingDate":1711512000000,"exchange":"NASDAQ","adjPreClose":6.43,"preHourTrading":{"tag":"盘前","latestPrice":6.2,"preClose":6.43,"latestTime":"09:29 EDT","volume":3,"amount":19.149999,"timestamp":1745328598412},"postHourTrading":{"tag":"盘后","latestPrice":6.32,"preClose":6.32,"latestTime":"16:05 EDT","volume":2,"amount":12.86,"timestamp":1745265912201},"volumeRatio":1.114813},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NTHI\",,,,,undefined,":{"symbol":"NTHI","floatShares":5219711,"roa":"-189.56%","roe":"--","lyrEps":-0.686076,"volumeRatio":1.114813,"shares":18745865,"dividePrice":0,"high":6.5887,"amplitude":0.119549,"preClose":6.43,"low":5.82,"week52Low":5.82,"pbRate":"-20.60","psRate":"1366.42","week52High":25,"institutionHeld":0,"latestPrice":6.05,"committee":-0.666667,"eps":-0.69,"divideRate":0,"volume":42196,"delay":0,"ttmEps":-0.69,"open":6.31,"prevYearClose":25,"prevWeekClose":6.95,"prevMonthClose":13.36,"prevQuarterClose":13.36,"fiveDayClose":7.95},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":1847121177,"yearFounded":2008,"address":"Two Dole Drive,Westlake Village,California,United States","zipCode":"91362","officePhone":"310-663-7831"},"stockCompanyDetail":{"websiteUrl":"http://www.neonctech.com","stockEarnings":[{"period":"1week","weight":-0.205},{"period":"1month","weight":-0.7472},{"period":"ytd","weight":-0.7472}],"compareEarnings":[{"period":"1week","weight":-0.0468},{"period":"1month","weight":-0.0888},{"period":"3month","weight":-0.1479},{"period":"6month","weight":-0.1109},{"period":"1year","weight":0.0378},{"period":"ytd","weight":-0.1232}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Neonc Technologies Holdings, Inc.于2023年1月5日注册成立,为特拉华州公司。作为一家临床阶段的生物制药公司,该公司一直专注于建立颅内恶性肿瘤的治疗方法,即位于大脑的侵袭性癌症。这些癌症类型包括原发性脑癌,如胶质母细胞瘤,和继发性脑癌,它们是通过全身其他癌症的转移扩散而来的,如黑色素瘤或乳腺癌和肺癌。大脑局限性恶性肿瘤特别难以治疗,因为血脑屏障阻止了大多数药物治疗剂有效进入大脑。因此,这些患者面临着预后不良和平均预期寿命缩短的问题。NeOnc正在开发新的药物递送方法,用于与新的候选药物联合使用。","exchange":"NASDAQ","name":"NeOnc Technologies Holdings","nameEN":"NeOnc Technologies Holdings"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"NTHI\",market:\"US\",,,undefined,":{"directors":[{"name":"Amir Heshmatpour","position":"Executive Chairman and Secretary"},{"name":"Thomas C. Chen","position":"Chief Executive Officer and Chairman"},{"name":"Keithly Garnett","position":"Chief Financial Officer and Director"},{"name":"Bader Almonawer","position":"Director"},{"name":"Jim Delshad","position":"Director"},{"name":"Ming Fu Chiang","position":"Director"},{"name":"Steven L. Giannotta","position":"Director"},{"name":"Victoria Medvec","position":"Director"}],"executives":[{"name":"Thomas C. Chen","position":"Chief Executive Officer and Chairman"},{"name":"Patrick Walters","position":"Chief Operating Officer"},{"name":"Keithly Garnett","position":"Chief Financial Officer and Director"},{"name":"Amir Heshmatpour","position":"Executive Chairman and Secretary"}]},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NTHI\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NTHI\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NTHI\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NTHI\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NTHI","date":"2025-04-21","current":-10.949629,"percent":1,"low":-26.074295,"twenty":-19.009816,"median":-15.282215,"eighty":-12.222621,"high":-10.949629,"avg":-16.051224,"sd":3.956914,"marketCap":130283761},"quantilePoints":[{"date":"2024-03-28","current":-18.899455,"twenty":-18.899455,"median":-18.899455,"eighty":-18.899455,"marketCap":282000000},{"date":"2025-03-28","current":-18.905834,"twenty":-19.009816,"median":-18.905834,"eighty":-18.902007,"marketCap":224950380},{"date":"2025-04-04","current":-15.093157,"twenty":-20.260752,"median":-18.902645,"eighty":-16.151884,"marketCap":179585386},{"date":"2025-04-11","current":-14.179375,"twenty":-19.504518,"median":-17.739974,"eighty":-15.124667,"marketCap":168712785},{"date":"2025-04-17","current":-11.028403,"twenty":-19.044476,"median":-15.392499,"eighty":-12.855967,"marketCap":131221055},{"date":"2025-04-21","current":-10.949629,"twenty":-19.009816,"median":-15.282215,"eighty":-12.222621,"marketCap":130283761}],"updateTime":1745345279437}}}